Loading...
Loading...
By Marcos Pascual - Wed, 12/17/2025 - 07:00
Mexico's pharmacy-adjacent clinics are expanding their primary care role with diagnostics and short-stay surgeries, writes Marcos Pascual Cruz.
Official links
View from the Top
By Sofía Garduño - Fri, 12/05/2025 - 16:54
Innovation and responsibility will drive the development of the healthcare sector, says Solventum’s Alejandra Muñoz.
View from the Top
By Sofía Garduño - Wed, 07/24/2024 - 10:00
Innovation is of no use if it does not reach the patients who need it, says Oswaldo Bernal, general manager for Bristol Myers Squibb Mexico.
Expert Contributor
By Marcos Pascual - Wed, 12/17/2025 - 07:00
Mexico's pharmacy-adjacent clinics are expanding their primary care role with diagnostics and short-stay surgeries, writes Marcos Pascual Cruz.
Expert Contributor
By Juan Carlos Molina - Wed, 12/11/2024 - 14:00
The CoSaDiM is tasked with projecting proposals and generating synergies between all industry key actors, writes Juan Carlos Molina.
https://mexicobusiness.news/tag/canifarma
More Health
By Perla Velasco - Thu, 11/03/2022 - 14:10
INSABI broke the supply agreement with UNOPS and stated that BIRMEX would be responsible for the national health supply in 2023.
By Perla Velasco - Fri, 10/21/2022 - 17:28
UNOPS reports on technical assistance in health supply as INSABI decides to not continue with its supply agreement for 2023.
By Rafael Gual - Thu, 10/13/2022 - 12:00
How are ethical business practices promoted in the pharmaceutical industry? Rafael Gual provides an answer.
By Miriam Bello - Thu, 09/08/2022 - 09:19
After the pandemic, global supply chains are restructuring their capabilities and Mexico stands to benefit from manufacturing nearshoring.
By Miriam Bello - Mon, 09/05/2022 - 12:24
Advances and ongoing challenges have paved the way for the transformation of Mexico’s health system.
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.
By Rafael Gual - Thu, 07/14/2022 - 10:00
Rafael Gual looks at the pharmaceutical industry in Mexico, discussing its relevance from both a social and economic viewpoint.
By Miriam Bello - Thu, 03/03/2022 - 17:05
The new acquisition law caused medicine shortages, with 24 million prescriptions being left unfilled at public health institutions.
By Antonio Gozain - Wed, 02/16/2022 - 16:21
An open dialogue between the public and private sectors is required to deliver medical supplies to patients across Mexico, agreed industry experts.
https://mexicobusiness.news/tag/canifarma
More Health
By Perla Velasco - Thu, 11/03/2022 - 14:10
INSABI broke the supply agreement with UNOPS and stated that BIRMEX would be responsible for the national health supply in 2023.
By Perla Velasco - Fri, 10/21/2022 - 17:28
UNOPS reports on technical assistance in health supply as INSABI decides to not continue with its supply agreement for 2023.
By Rafael Gual - Thu, 10/13/2022 - 12:00
How are ethical business practices promoted in the pharmaceutical industry? Rafael Gual provides an answer.
By Miriam Bello - Thu, 09/08/2022 - 09:19
After the pandemic, global supply chains are restructuring their capabilities and Mexico stands to benefit from manufacturing nearshoring.
By Miriam Bello - Mon, 09/05/2022 - 12:24
Advances and ongoing challenges have paved the way for the transformation of Mexico’s health system.
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.
By Rafael Gual - Thu, 07/14/2022 - 10:00
Rafael Gual looks at the pharmaceutical industry in Mexico, discussing its relevance from both a social and economic viewpoint.
By Miriam Bello - Thu, 03/03/2022 - 17:05
The new acquisition law caused medicine shortages, with 24 million prescriptions being left unfilled at public health institutions.
By Antonio Gozain - Wed, 02/16/2022 - 16:21
An open dialogue between the public and private sectors is required to deliver medical supplies to patients across Mexico, agreed industry experts.
